Predicting Blood Glucose with an LSTM and Bi-LSTM Based Deep Neural Network

A deep learning network was used to predict future blood glucose levels, as this can permit diabetes patients to take action before imminent hyperglycaemia and hypoglycaemia. A sequential model with one long-short-term memory (LSTM) layer, one bidirectional LSTM layer and several fully connected layers was used to predict blood glucose levels for different prediction horizons. The method was trained and tested on 26 datasets from 20 real patients. The proposed network outperforms the baseline methods in terms of all evaluation criteria.Comment: 5 pages, submitted to 2018 14th Symposium on Neural Networks and Applications (NEUREL

Precision medicine and artificial intelligence : a pilot study on deep learning for hypoglycemic events detection based on ECG

Tracking the fluctuations in blood glucose levels is important for healthy subjects and crucial diabetic patients. Tight glucose monitoring reduces the risk of hypoglycemia, which can result in a series of complications, especially in diabetic patients, such as confusion, irritability, seizure and can even be fatal in specific conditions. Hypoglycemia affects the electrophysiology of the heart. However, due to strong inter-subject heterogeneity, previous studies based on a cohort of subjects failed to deploy electrocardiogram (ECG)-based hypoglycemic detection systems reliably. The current study used personalised medicine approach and Artificial Intelligence (AI) to automatically detect nocturnal hypoglycemia using a few heartbeats of raw ECG signal recorded with non-invasive, wearable devices, in healthy individuals, monitored 24 hours for 14 consecutive days. Additionally, we present a visualisation method enabling clinicians to visualise which part of the ECG signal (e.g., T-wave, ST-interval) is significantly associated with the hypoglycemic event in each subject, overcoming the intelligibility problem of deep-learning methods. These results advance the feasibility of a real-time, non-invasive hypoglycemia alarming system using short excerpts of ECG signal

Precision medicine and artificial intelligence : a pilot study on deep learning for hypoglycemic events detection based on ECG

Tracking the fluctuations in blood glucose levels is important for healthy subjects and crucial diabetic patients. Tight glucose monitoring reduces the risk of hypoglycemia, which can result in a series of complications, especially in diabetic patients, such as confusion, irritability, seizure and can even be fatal in specific conditions. Hypoglycemia affects the electrophysiology of the heart. However, due to strong inter-subject heterogeneity, previous studies based on a cohort of subjects failed to deploy electrocardiogram (ECG)-based hypoglycemic detection systems reliably. The current study used personalised medicine approach and Artificial Intelligence (AI) to automatically detect nocturnal hypoglycemia using a few heartbeats of raw ECG signal recorded with non-invasive, wearable devices, in healthy individuals, monitored 24 hours for 14 consecutive days. Additionally, we present a visualisation method enabling clinicians to visualise which part of the ECG signal (e.g., T-wave, ST-interval) is significantly associated with the hypoglycemic event in each subject, overcoming the intelligibility problem of deep-learning methods. These results advance the feasibility of a real-time, non-invasive hypoglycemia alarming system using short excerpts of ECG signal

Hybrid Deep Learning Algorithm for Insulin Dosage Prediction Using Blockchain and IOT

This paper addresses the problem of predicting insulin dosage in diabetes patients using the PSO-LSTM, COA-LSTM, and LOA-LSTM algorithms. Accurate insulin dosage prediction is crucial in effectively managing Diabetes and maintaining blood glucose levels within the desired range. The study proposes a novel approach that combines particle swarm optimization (PSO) with the long short-term memory (LSTM) model. PSO is used to optimize the LSTM's parameters, enhancing its prediction capabilities specifically for insulin dosage. Additionally, two other techniques, COA-LSTM and LOA-LSTM, are introduced for comparison purposes. The algorithms utilize a dataset comprising relevant features such as past insulin dosages, blood glucose levels, carbohydrate intake, and physical activity. These features are fed into the PSO-LSTM, COA-LSTM, and LOA-LSTM models to predict the appropriate insulin dosage for future time points. The results demonstrate the effectiveness of the proposed PSO-LSTM algorithm in accurately predicting insulin dosage, surpassing the performance of COA-LSTM and LOA-LSTM. The PSO-LSTM model achieves a high level of accuracy, aiding in personalized and precise insulin administration for diabetes patients. By leveraging the power of PSO optimization and LSTM modeling, this research improves the accuracy and reliability of insulin dosage prediction. The findings highlight the potential of the PSO-LSTM algorithm as a valuable tool for healthcare professionals in optimizing diabetes management and enhancing patient outcomes

Processing of Electronic Health Records using Deep Learning: A review

Availability of large amount of clinical data is opening up new research avenues in a number of fields. An exciting field in this respect is healthcare, where secondary use of healthcare data is beginning to revolutionize healthcare. Except for availability of Big Data, both medical data from healthcare institutions (such as EMR data) and data generated from health and wellbeing devices (such as personal trackers), a significant contribution to this trend is also being made by recent advances on machine learning, specifically deep learning algorithms

Blood Glucose Forecasting using LSTM Variants under the Context of Open Source Artificial Pancreas System

High accuracy of blood glucose prediction over the long term is essential for preventative diabetes management. The emerging closed-loop insulin delivery system such as the artificial pancreas system (APS) provides opportunities for improved glycaemic control for patients with type 1 diabetes. Existing blood glucose studies are proven effective only within 30 minutes but the accuracy deteriorates drastically when the prediction horizon increases to 45 minutes and 60 minutes. Deep learning, especially for long short term memory (LSTM) and its variants have recently been applied in various areas to achieve state-of-the-art results in tasks with complex time series data. In this study, we present deep LSTM based models that are capable of forecasting long term blood glucose levels with improved prediction and clinical accuracy. We evaluate our approach using 20 cases(878,000 glucose values) from Open Source Artificial Pancreas System (OpenAPS). On 30-minutes and 45-minutes prediction, our Stacked-LSTM achieved the best performance with Root-Mean-Square-Error (RMSE) marks 11.96 & 15.81 and Clark-Grid-ZoneA marks 0.887 & 0.784. In terms of 60-minutes prediction, our ConvLSTM has the best performance with RMSE = 19.6 and Clark-Grid-ZoneA=0.714. Our models outperform existing methods in both prediction and clinical accuracy. This research can hopefully support patients with type 1 diabetes to better manage their behavior in a more preventative way and can be used in future real APS context

Basal Glucose Control in Type 1 Diabetes using Deep Reinforcement Learning: An In Silico Validation

People with Type 1 diabetes (T1D) require regular exogenous infusion of insulin to maintain their blood glucose concentration in a therapeutically adequate target range. Although the artificial pancreas and continuous glucose monitoring have been proven to be effective in achieving closed-loop control, significant challenges still remain due to the high complexity of glucose dynamics and limitations in the technology. In this work, we propose a novel deep reinforcement learning model for single-hormone (insulin) and dual-hormone (insulin and glucagon) delivery. In particular, the delivery strategies are developed by double Q-learning with dilated recurrent neural networks. For designing and testing purposes, the FDA-accepted UVA/Padova Type 1 simulator was employed. First, we performed long-term generalized training to obtain a population model. Then, this model was personalized with a small data-set of subject-specific data. In silico results show that the single and dual-hormone delivery strategies achieve good glucose control when compared to a standard basal-bolus therapy with low-glucose insulin suspension. Specifically, in the adult cohort (n=10), percentage time in target range [70, 180] mg/dL improved from 77.6% to 80.9% with single-hormone control, and to $85.6\%$ with dual-hormone control. In the adolescent cohort (n=10), percentage time in target range improved from 55.5% to 65.9% with single-hormone control, and to 78.8% with dual-hormone control. In all scenarios, a significant decrease in hypoglycemia was observed. These results show that the use of deep reinforcement learning is a viable approach for closed-loop glucose control in T1D

Personalised Interventions - A Precision Approach for the Next Generation of Dietary Intervention Studies

Acknowledgments The research of Baukje de Roos is supported by the Scottish Government’s Rural and Environment Science and Analytical Services Division (RESAS). Lorraine Brennan acknowledges The European Research Council ERC (647783). Conflicts of Interest The authors declare no conflict of interest.Peer reviewedPublisher PD